骨科手术中的骨骼健康优化
这项回顾性研究评估了124例因骨科手术转诊进行骨骼健康优化的≥50岁患者,发现骨质疏松、骨微结构退化、既往骨折和高骨折风险普遍存在,91%患者符合美国国家骨质疏松基金会治疗阈值,建议对≥50岁择期骨科手术患者考虑FRAX等骨骼健康筛查。
要点
- 转诊患者中45%女性和20%男性存在骨质疏松,仅3%女性和10%男性骨密度正常。
- 91%患者符合NOF骨质疏松治疗阈值,75%接受了治疗(45%促骨形成,30%抗骨吸收)。
- 机会性CT识别60%患者可能骨质疏松,骨小梁评分显示34%骨微结构退化、30%部分退化。
核心结论
- 该队列中骨质疏松、骨微结构退化、既往骨折和高骨折风险普遍存在,提示对≥50岁择期骨科手术患者应考虑骨骼健康筛查包括FRAX评估。
研究设计与样本
- 回顾性研究纳入124例因骨骼健康优化转诊、≥50岁且为关节置换或胸腰椎手术候选者的患者,收集FRAX风险因素和DXA结果,并评估机会性CT和骨小梁评分。
主要发现
- 所有患者均由骨科医生转诊,平均年龄69.2岁,83%为女性,97%为白人,56%有既往骨折史。
- 女性历史身高丢失平均5.3±3.3 cm,男性6.0±3.6 cm。
- 髋、脊柱或腕部最低T值平均女性-2.43±0.90,男性-2.04±0.81(p<0.08)。
- 骨质疏松(T值≤-2.5)存在于45%女性和20%男性,仅3%女性和10%男性骨密度正常。
- 机会性CT识别60%患者可能骨质疏松,骨小梁评分显示34%骨微结构退化、30%部分退化。
关键数值与推荐
- 91%患者符合NOF骨质疏松治疗阈值。
- 75%患者接受了治疗,其中45%为促骨形成治疗,30%为抗骨吸收治疗。
临床怎么用
- 对≥50岁拟行关节置换或胸腰椎手术的患者,术前可考虑FRAX评估和骨骼健康筛查以识别骨质疏松并优化治疗。
局限性
- 本研究为回顾性设计,证据等级为预后Level IV。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Osteoporosis is associated with adverse orthopaedic surgical outcomes. Bone health optimization is a preoperative intervention intended to reduce the likelihood of postoperative complications. We aimed to characterize a patient cohort referred for bone health optimization to test the hypothesis that poor bone quality is common in orthopaedic surgery and that many such patients meet guidelines for osteoporosis treatment. METHODS: This retrospective study evaluated 124 patients referred for bone health optimization who were ≥50 years of age and candidates for arthroplasty or thoracolumbar surgery. The Fracture Risk Assessment Tool (FRAX) risk factors and dual x-ray absorptiometry (DXA) results were collected. When available, opportunistic computed tomographic (CT) imaging and the trabecular bone score were evaluated. The World Health Organization (WHO) diagnostic and National Osteoporosis Foundation (NOF) treatment guidelines were applied. RESULTS: All patients were referred by their orthopaedic surgeon; their mean age was 69.2 years, 83% of patients were female, 97% were Caucasian, and 56% had sustained a previous fracture. The mean historical height loss (and standard deviation) was 5.3 ± 3.3 cm for women and 6.0 ± 3.6 cm for men. The mean lowest T-score of the hip, spine, or wrist was -2.43 ± 0.90 points in women and -2.04 ± 0.81 points in men (p < 0.08). Osteoporosis (T-score of ≤-2.5 points) was present in 45% of women and 20% of men; only 3% of women and 10% of men had normal bone mineral density. Opportunistic CT scans identified 60% of patients as likely having osteoporosis. The trabecular bone score identified 34% of patients with degraded bone microarchitecture and 30% of patients with partially degraded bone microarchitecture. The NOF threshold for osteoporosis treatment was met in 91% of patients. Treatment was prescribed in 75% of patients (45% anabolic therapy and 30% antiresorptive therapy). CONCLUSIONS: Osteoporosis, degraded bone microarchitecture, prior fracture, and elevated fracture risk were common. Given the high prevalence of impaired bone health in this cohort, we believe that bone health screening, including FRAX assessment, should be considered in selected patients undergoing orthopaedic surgery as part of the preoperative optimization for all adults who are ≥50 years of age. LEVEL OF EVIDENCE: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Kadri A, Binkley N, Hare KJ, et al. Bone Health Optimization in Orthopaedic Surgery. J Bone Joint Surg Am. 2020. PMID: 31977823. doi:10.2106/JBJS.19.00999
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。